Promore Pharma: PXL01 deal expansion with PRP
Research Note
2018-05-07
09:32
Promore Pharma announced earlier today they have out-licensed PXL01 to PharmaResearch Products (PRP) for preventing fibrosis after spinal surgery. The deal is an extension of a previous collaboration.
MS
Mathias Spinnars
Disclosures and disclaimers